Want to see ACXP full AI Analyst Report?
Acurx Pharmaceuticals (ACXP) Q2 2024 Earnings Report
ACXP Q2 2024 EPS Results
- Actual EPS
- -$5.20
- Consensus EPS
- -$3.30
- Beat/Miss
- Missed by -$1.90
- One Year Ago EPS
- -$5.60
ACXP Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/09/2024
- Time
- Before Open
- Conference Call
- Friday, August 9, 2024
ACXP Upcoming Earnings
Acurx Pharmaceuticals's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
ACXP Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
ACXP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.38- | -1.23 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -0.38-0.53 | -1.89 | 71.96% (+1.36) | |
| May 12, 2026 | 2026 (Q1) | -1.20-0.62 | -2.2 | 71.82% (+1.58) | |
| Mar 13, 2026 | 2025 (Q4) | -1.01-0.73 | -3.2 | 77.19% (+2.47) | |
| Nov 12, 2025 | 2025 (Q3) | -1.31-1.23 | -3.4 | 63.82% (+2.17) | |
| Aug 12, 2025 | 2025 (Q2) | -2.33-1.89 | -5.2 | 63.65% (+3.31) | |
| May 13, 2025 | 2025 (Q1) | -2.60-2.20 | -5.6 | 60.71% (+3.40) | |
| Mar 18, 2025 | 2024 (Q4) | -3.50-3.20 | -7.4 | 56.76% (+4.20) | |
| Nov 13, 2024 | 2024 (Q3) | -2.90-3.40 | -4.8 | 29.17% (+1.40) | |
| Aug 09, 2024 | 2024 (Q2) | -3.30-5.20 | -5.6 | 7.14% (+0.40) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed